메뉴 건너뛰기




Volumn 25, Issue 9, 2014, Pages 1691-1700

Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): A consensus proposal

(24)  Valent, P a   Sotlar, K b   Sperr, W R a   Escribano, L c   Yavuz, S d   Reiter, A e   George, T I f   Kluin Nelemans, H C g   Hermine, O h   Butterfield, J H i   Hagglund H j   Ustun, C k   Hornick, J L l   Triggiani, M m   Radia, D n   Akin, C l   Hartmann, K o   Gotlib, J p   Schwartz, L B q   Verstovsek, S r   more..

c CSIC   (Spain)

Author keywords

KIT D816V; Leukemia; Mast cells; Mastocytosis; Prognostication; Tryptase

Indexed keywords

ACUTE MAST CELL LEUKEMIA; BONE MARROW BIOPSY; CANCER DIAGNOSIS; CANCER GRADING; CANCER MORPHOLOGY; CANCER PROGNOSIS; CANCER STAGING; CELL DIFFERENTIATION; CELL MATURATION; CHRONIC MAST CELL LEUKEMIA; CLINICAL EFFECTIVENESS; CYTOPATHOLOGY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; LEUKEMIA; MAST CELL; MAST CELL LEUKEMIA; METASTASIS; MYELOMASTOCYTIC LEUKEMIA; NOMENCLATURE; PATIENT SELECTION; PRIMARY TUMOR; PRIORITY JOURNAL; REVIEW; SARCOMA; SYSTEMIC MASTOCYTOSIS; ADVANCED CANCER; BONE MARROW CELL; CANCER CLASSIFICATION; CANCER INFILTRATION; CANCER PATIENT; CELL EXPANSION; CHRONIC LEUKEMIA; CONSENSUS; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EUROPEAN UNION; GOLD STANDARD; MYELOID LEUKEMIA; ONCOLOGICAL PARAMETERS; PRACTICE GUIDELINE; TREATMENT RESPONSE; UNITED STATES; WORLD HEALTH ORGANIZATION; BONE MARROW EXAMINATION; CLASSIFICATION; DISEASE COURSE; LEUKEMIA, MAST-CELL; LEUKEMIA, MYELOMONOCYTIC, ACUTE; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MASTOCYTOSIS; PATHOLOGY;

EID: 84905257819     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdu047     Document Type: Review
Times cited : (101)

References (56)
  • 1
    • 0034983045 scopus 로고    scopus 로고
    • Diagnostic criteria and classification of mastocytosis: a consensus proposal
    • Valent P, Horny HP, Escribano L et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001; 25(7): 603-625.
    • (2001) Leuk Res , vol.25 , Issue.7 , pp. 603-625
    • Valent, P.1    Horny, H.P.2    Escribano, L.3
  • 2
    • 0003053208 scopus 로고    scopus 로고
    • Mastocytosis (mast cell disease)
    • Jaffe ES, Harris NL, Stein H et al. (eds), World Health Organization (WHO) Classification of Tumours. France: IARC Press Lyon
    • Valent P, Horny H-P, Li CY et al. Mastocytosis (mast cell disease). In Jaffe ES, Harris NL, Stein H et al. (eds), World Health Organization (WHO) Classification of Tumours. Pathology & Genetics. Tumours of Haematopoietic and Lymphoid Tissues. France: IARC Press Lyon, 2001; 291-302.
    • (2001) Pathology & Genetics, Tumours of Haematopoietic and Lymphoid Tissues , pp. 291-302
    • Valent, P.1    Horny, H.-P.2    Li, C.Y.3
  • 3
    • 61549132662 scopus 로고    scopus 로고
    • Mastocytosis (mast cell disease)
    • Swerdlow SH, Campo E, Harris NL et al. (eds), World Health Organization (WHO) Classification of Tumours. Lyon, France: IARC Press
    • Horny HP, Akin C, Metcalfe DD et al. Mastocytosis (mast cell disease). In Swerdlow SH, Campo E, Harris NL et al. (eds), World Health Organization (WHO) Classification of Tumours. Pathology & Genetics. Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2008; 54-63.
    • (2008) Pathology & Genetics, Tumours of Haematopoietic and Lymphoid Tissues , pp. 54-63
    • Horny, H.P.1    Akin, C.2    Metcalfe, D.D.3
  • 4
    • 0141506139 scopus 로고    scopus 로고
    • Mast cell proliferative disorders: current view on variants recognized by the World Health Organization
    • Valent P, Akin C, Sperr WR et al. Mast cell proliferative disorders: current view on variants recognized by the World Health Organization. Hematol Oncol Clin North Am 2003; 17(5): 1227-1241.
    • (2003) Hematol Oncol Clin North Am , vol.17 , Issue.5 , pp. 1227-1241
    • Valent, P.1    Akin, C.2    Sperr, W.R.3
  • 5
    • 0034983239 scopus 로고    scopus 로고
    • Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis
    • Sperr WR, Escribano L, Jordan JH et al. Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis. Leuk Res 2001; 25(7): 529-536.
    • (2001) Leuk Res , vol.25 , Issue.7 , pp. 529-536
    • Sperr, W.R.1    Escribano, L.2    Jordan, J.H.3
  • 6
    • 67651120132 scopus 로고    scopus 로고
    • Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors
    • Lim KH, Tefferi A, Lasho TL et al. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 2009; 113(23): 5727-5736.
    • (2009) Blood , vol.113 , Issue.23 , pp. 5727-5736
    • Lim, K.H.1    Tefferi, A.2    Lasho, T.L.3
  • 7
    • 69349102308 scopus 로고    scopus 로고
    • Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients
    • Escribano L, Alvarez-Twose I, Sánchez-Muñoz L et al. Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients. J Allergy Clin Immunol 2009; 124(3): 514-521.
    • (2009) J Allergy Clin Immunol , vol.124 , Issue.3 , pp. 514-521
    • Escribano, L.1    Alvarez-Twose, I.2    Sánchez-Muñoz, L.3
  • 8
    • 70449706224 scopus 로고    scopus 로고
    • Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies
    • Pardanani A, Lim KH, Lasho TL et al. Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies. Blood 2009; 114(18): 3769-3772.
    • (2009) Blood , vol.114 , Issue.18 , pp. 3769-3772
    • Pardanani, A.1    Lim, K.H.2    Lasho, T.L.3
  • 9
    • 0022969412 scopus 로고
    • Mast cell leukemia: report of a case and review of the literature
    • Travis WD, Li CY, Hoagland HC et al. Mast cell leukemia: report of a case and review of the literature. Mayo Clinic Proc 1986; 61(12): 957-966.
    • (1986) Mayo Clinic Proc , vol.61 , Issue.12 , pp. 957-966
    • Travis, W.D.1    Li, C.Y.2    Hoagland, H.C.3
  • 10
    • 0022485244 scopus 로고
    • Mast cell leukaemia: evidence for bone marrow origin of the pathologic clone
    • Dalton R, Chan L, Batten E et al. Mast cell leukaemia: evidence for bone marrow origin of the pathologic clone. Br J Haematol 1986; 64(2): 397-406.
    • (1986) Br J Haematol , vol.64 , Issue.2 , pp. 397-406
    • Dalton, R.1    Chan, L.2    Batten, E.3
  • 11
    • 0345772088 scopus 로고    scopus 로고
    • Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria
    • Valent P, Akin C, Sperr WR et al. Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria. Leuk Res 2003; 27(7): 635-641.
    • (2003) Leuk Res , vol.27 , Issue.7 , pp. 635-641
    • Valent, P.1    Akin, C.2    Sperr, W.R.3
  • 13
    • 9044235583 scopus 로고    scopus 로고
    • A case of malignant mastocytosis with circulating mast cell precursors: biologic and phenotypic characterization of the malignant clone
    • Baghestanian M, Bankl HC, Sillaber C et al. A case of malignant mastocytosis with circulating mast cell precursors: biologic and phenotypic characterization of the malignant clone. Leukemia 1996; 10(1): 159-166.
    • (1996) Leukemia , vol.10 , Issue.1 , pp. 159-166
    • Baghestanian, M.1    Bankl, H.C.2    Sillaber, C.3
  • 14
    • 0034981905 scopus 로고    scopus 로고
    • Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis
    • Escribano L, Díaz-Agustín B, Bellas C et al. Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis. Leuk Res 2001; 25(7): 563-570.
    • (2001) Leuk Res , vol.25 , Issue.7 , pp. 563-570
    • Escribano, L.1    Díaz-Agustín, B.2    Bellas, C.3
  • 15
    • 77949268924 scopus 로고    scopus 로고
    • Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes
    • Teodosio C, García-Montero AC, Jara-Acevedo M et al. Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes. J Allergy Clin Immunol 2010; 125(3): 719-726.
    • (2010) J Allergy Clin Immunol , vol.125 , Issue.3 , pp. 719-726
    • Teodosio, C.1    García-Montero, A.C.2    Jara-Acevedo, M.3
  • 16
    • 84875759168 scopus 로고    scopus 로고
    • Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosis
    • Teodosio C, García-Montero AC, Jara-Acevedo M et al. Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosis. J Allergy Clin Immunol 2013; 131(4): 1213-1224.
    • (2013) J Allergy Clin Immunol , vol.131 , Issue.4 , pp. 1213-1224
    • Teodosio, C.1    García-Montero, A.C.2    Jara-Acevedo, M.3
  • 17
    • 0032523149 scopus 로고    scopus 로고
    • Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications
    • Escribano L, Orfao A, Díaz-Agustin B et al. Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications. Blood 1998; 91(8): 2731-2736.
    • (1998) Blood , vol.91 , Issue.8 , pp. 2731-2736
    • Escribano, L.1    Orfao, A.2    Díaz-Agustin, B.3
  • 18
    • 0030900209 scopus 로고    scopus 로고
    • Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia
    • Escribano L, Orfao A, Villarrubia J et al. Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia. Cytometry 1997; 30(2): 98-102.
    • (1997) Cytometry , vol.30 , Issue.2 , pp. 98-102
    • Escribano, L.1    Orfao, A.2    Villarrubia, J.3
  • 19
    • 79953331926 scopus 로고    scopus 로고
    • Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis
    • Sotlar K, Cerny-Reiterer S, Petat-Dutter K et al. Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis. Mod Pathol 2011; 24(4): 585-595.
    • (2011) Mod Pathol , vol.24 , Issue.4 , pp. 585-595
    • Sotlar, K.1    Cerny-Reiterer, S.2    Petat-Dutter, K.3
  • 20
    • 79955059422 scopus 로고    scopus 로고
    • Aberrant expression of CD30 in aggressive systemic mastocytosis and mast cell leukemia: a differential diagnosis to consider in aggressive hematopoietic CD30-positive neoplasms
    • Valent P, Sotlar K, Horny HP. Aberrant expression of CD30 in aggressive systemic mastocytosis and mast cell leukemia: a differential diagnosis to consider in aggressive hematopoietic CD30-positive neoplasms. Leuk Lymphoma 2011; 52 (5): 740-744.
    • (2011) Leuk Lymphoma , vol.52 , Issue.5 , pp. 740-744
    • Valent, P.1    Sotlar, K.2    Horny, H.P.3
  • 21
    • 84887816251 scopus 로고    scopus 로고
    • CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis
    • Morgado JM, Perbellini O, Johnson RC et al. CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis. Histopathology 2013; 63: 780-787.
    • (2013) Histopathology , vol.63 , pp. 780-787
    • Morgado, J.M.1    Perbellini, O.2    Johnson, R.C.3
  • 22
    • 77955642537 scopus 로고    scopus 로고
    • Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives
    • Arock M, Valent P. Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives. Expert Rev Hematol 2010; 3(4): 497-516.
    • (2010) Expert Rev Hematol , vol.3 , Issue.4 , pp. 497-516
    • Arock, M.1    Valent, P.2
  • 23
    • 79955998389 scopus 로고    scopus 로고
    • A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib
    • Mital A, Piskorz A, Lewandowski K et al. A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib. Eur J Haematol 2011; 86(6): 531-535.
    • (2011) Eur J Haematol , vol.86 , Issue.6 , pp. 531-535
    • Mital, A.1    Piskorz, A.2    Lewandowski, K.3
  • 24
    • 84874430998 scopus 로고    scopus 로고
    • Mast cell leukaemia: c-KIT mutations are not always positive
    • Joris M, Georgin-Lavialle S, Chandesris MO et al. Mast cell leukaemia: c-KIT mutations are not always positive. Case Rep Hematol 2012; 2012: 517546.
    • (2012) Case Rep Hematol , vol.2012 , pp. 517546
    • Joris, M.1    Georgin-Lavialle, S.2    Chandesris, M.O.3
  • 25
    • 84862578484 scopus 로고    scopus 로고
    • Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor
    • Georgin-Lavialle S, Lhermitte L, Suarez F et al. Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor. Eur J Haematol 2012; 89(1): 47-52.
    • (2012) Eur J Haematol , vol.89 , Issue.1 , pp. 47-52
    • Georgin-Lavialle, S.1    Lhermitte, L.2    Suarez, F.3
  • 26
    • 84862005479 scopus 로고    scopus 로고
    • Mast-cell leukemia exome sequencing reveals a mutation in the IgE mast-cell receptor ß chain and KIT V654A
    • Spector MS, Iossifov I, Kritharis A et al. Mast-cell leukemia exome sequencing reveals a mutation in the IgE mast-cell receptor ß chain and KIT V654A. Leukemia 2012; 26(6): 1422-1425.
    • (2012) Leukemia , vol.26 , Issue.6 , pp. 1422-1425
    • Spector, M.S.1    Iossifov, I.2    Kritharis, A.3
  • 27
    • 84872762495 scopus 로고    scopus 로고
    • Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression
    • Verstovsek S. Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression. Eur J Haematol 2013; 90(2): 89-98.
    • (2013) Eur J Haematol , vol.90 , Issue.2 , pp. 89-98
    • Verstovsek, S.1
  • 28
    • 0032104728 scopus 로고    scopus 로고
    • In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation
    • Beghini A, Cairoli R, Morra E et al. In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation. Blood Cells Mol Dis. 1998; 24(2): 262-270.
    • (1998) Blood Cells Mol Dis. , vol.24 , Issue.2 , pp. 262-270
    • Beghini, A.1    Cairoli, R.2    Morra, E.3
  • 29
    • 27144506215 scopus 로고    scopus 로고
    • Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation
    • Gotlib J, Berubé C, Growney JD et al. Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation. Blood 2005; 106(8): 2865-2870.
    • (2005) Blood , vol.106 , Issue.8 , pp. 2865-2870
    • Gotlib, J.1    Berubé, C.2    Growney, J.D.3
  • 30
    • 84876130624 scopus 로고    scopus 로고
    • A case of systemic mastocytosis associated with acute myeloid leukemia terminating as aleukemic mast cell leukemia after allogeneic hematopoietic stem cell transplantation
    • Bae MH, Kim HK, Park CJ et al. A case of systemic mastocytosis associated with acute myeloid leukemia terminating as aleukemic mast cell leukemia after allogeneic hematopoietic stem cell transplantation. Ann Lab Med. 2013; 33(2): 125-129.
    • (2013) Ann Lab Med. , vol.33 , Issue.2 , pp. 125-129
    • Bae, M.H.1    Kim, H.K.2    Park, C.J.3
  • 32
    • 41449093588 scopus 로고    scopus 로고
    • Aggressive systemic mastocytosis with sarcoma-like growth in the skeleton, leukemic progression, and partial loss of mast cell differentiation antigens
    • Krauth MT, Födinger M, Rebuzzi L et al. Aggressive systemic mastocytosis with sarcoma-like growth in the skeleton, leukemic progression, and partial loss of mast cell differentiation antigens. Haematologica 2007; 92(12): e126-e129.
    • (2007) Haematologica , vol.92 , Issue.12
    • Krauth, M.T.1    Födinger, M.2    Rebuzzi, L.3
  • 33
    • 85047685367 scopus 로고    scopus 로고
    • Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells
    • Valent P, Samorapoompichit P, Sperr WR et al. Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells. Hematol J 2002; 3(2): 90-94.
    • (2002) Hematol J , vol.3 , Issue.2 , pp. 90-94
    • Valent, P.1    Samorapoompichit, P.2    Sperr, W.R.3
  • 34
    • 26444578394 scopus 로고    scopus 로고
    • Myelomastocytic leukemia: evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantation
    • Sperr WR, Drach J, Hauswirth AW et al. Myelomastocytic leukemia: evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantation. Clin Cancer Res 2005; 11: 6787-6792.
    • (2005) Clin Cancer Res , vol.11 , pp. 6787-6792
    • Sperr, W.R.1    Drach, J.2    Hauswirth, A.W.3
  • 35
    • 77955483681 scopus 로고    scopus 로고
    • Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge
    • Arredondo AR, Gotlib J, Shier L et al. Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge. Am J Hematol 2010; 85(8): 600-606.
    • (2010) Am J Hematol , vol.85 , Issue.8 , pp. 600-606
    • Arredondo, A.R.1    Gotlib, J.2    Shier, L.3
  • 36
    • 0027997487 scopus 로고
    • Kit ligand/mast cell growth factorindependent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis
    • Valent P, Spanblöchl E, Bankl HC et al. Kit ligand/mast cell growth factorindependent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis. Blood 1994; 84(12): 4322-4332.
    • (1994) Blood , vol.84 , Issue.12 , pp. 4322-4332
    • Valent, P.1    Spanblöchl, E.2    Bankl, H.C.3
  • 37
    • 0032890734 scopus 로고    scopus 로고
    • Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cells
    • Wimazal F, Sperr WR, Horny HP et al. Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cells. Am J Hematol 1999; 61(1): 66-77.
    • (1999) Am J Hematol , vol.61 , Issue.1 , pp. 66-77
    • Wimazal, F.1    Sperr, W.R.2    Horny, H.P.3
  • 38
    • 34249333084 scopus 로고    scopus 로고
    • Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria
    • Valent P, Akin C, Escribano L et al. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007; 37(6): 435-453.
    • (2007) Eur J Clin Invest , vol.37 , Issue.6 , pp. 435-453
    • Valent, P.1    Akin, C.2    Escribano, L.3
  • 39
    • 12144286558 scopus 로고    scopus 로고
    • Spanish Network on Mastocytosis (REMA). Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA)
    • Escribano L, Diaz-Agustin B, López A et al. Spanish Network on Mastocytosis (REMA). Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA). Cytometry B Clin Cytom 2004; 58(1): 1-8.
    • (2004) Cytometry B Clin Cytom , vol.58 , Issue.1 , pp. 1-8
    • Escribano, L.1    Diaz-Agustin, B.2    López, A.3
  • 40
    • 67349145955 scopus 로고    scopus 로고
    • Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates
    • Tefferi A, Levine RL, Lim KH et al. Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates. Leukemia. 2009; 23(5): 900-904.
    • (2009) Leukemia. , vol.23 , Issue.5 , pp. 900-904
    • Tefferi, A.1    Levine, R.L.2    Lim, K.H.3
  • 41
    • 79952336888 scopus 로고    scopus 로고
    • Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis
    • Wilson TM, Maric I, Simakova O et al. Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis. Haematologica 2011; 96(3): 459-463.
    • (2011) Haematologica , vol.96 , Issue.3 , pp. 459-463
    • Wilson, T.M.1    Maric, I.2    Simakova, O.3
  • 42
    • 84887658376 scopus 로고    scopus 로고
    • Comprehensive mutational profiling in advanced systemic mastocytosis
    • Schwaab J, Schnittger S, Sotlar K et al. Comprehensive mutational profiling in advanced systemic mastocytosis. Blood 2013; 122(14): 2460-2466.
    • (2013) Blood , vol.122 , Issue.14 , pp. 2460-2466
    • Schwaab, J.1    Schnittger, S.2    Sotlar, K.3
  • 43
    • 0021804366 scopus 로고
    • Bone marrow findings in systemic mastocytosis
    • Horny HP, Parwaresch MR, Lennert K. Bone marrow findings in systemic mastocytosis. Hum Pathol 1985; 16(8): 808-814.
    • (1985) Hum Pathol , vol.16 , Issue.8 , pp. 808-814
    • Horny, H.P.1    Parwaresch, M.R.2    Lennert, K.3
  • 44
    • 0031682307 scopus 로고    scopus 로고
    • Diagnostic value of immunostaining for tryptase in patients with mastocytosis
    • Horny HP, Sillaber C, Menke D et al. Diagnostic value of immunostaining for tryptase in patients with mastocytosis. Am J Surg Pathol 1998; 22(9): 1132-1140.
    • (1998) Am J Surg Pathol , vol.22 , Issue.9 , pp. 1132-1140
    • Horny, H.P.1    Sillaber, C.2    Menke, D.3
  • 45
    • 0034986344 scopus 로고    scopus 로고
    • Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings
    • Horny HP, Valent P. Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings. Leuk Res 2001; 25(7): 543-551.
    • (2001) Leuk Res , vol.25 , Issue.7 , pp. 543-551
    • Horny, H.P.1    Valent, P.2
  • 46
    • 33644763309 scopus 로고    scopus 로고
    • The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers
    • Horny HP, Sotlar K, Stellmacher F et al. The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers. J Clin Pathol 2006; 59(3): 298-302.
    • (2006) J Clin Pathol , vol.59 , Issue.3 , pp. 298-302
    • Horny, H.P.1    Sotlar, K.2    Stellmacher, F.3
  • 47
    • 25844516537 scopus 로고    scopus 로고
    • Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia
    • Krokowski M, Sotlar K, Krauth MT et al. Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia. Am J Clin Pathol 2005; 124(4): 560-568.
    • (2005) Am J Clin Pathol , vol.124 , Issue.4 , pp. 560-568
    • Krokowski, M.1    Sotlar, K.2    Krauth, M.T.3
  • 48
    • 5044230101 scopus 로고    scopus 로고
    • CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens
    • Sotlar K, Horny HP, Simonitsch I et al. CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens. Am J Surg Pathol 2004; 28(10): 1319-1325.
    • (2004) Am J Surg Pathol , vol.28 , Issue.10 , pp. 1319-1325
    • Sotlar, K.1    Horny, H.P.2    Simonitsch, I.3
  • 49
    • 0034987361 scopus 로고    scopus 로고
    • Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L)
    • Jordan JH, Walchshofer S, Jurecka W et al. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L). Hum Pathol 2001; 32(5): 545-552.
    • (2001) Hum Pathol , vol.32 , Issue.5 , pp. 545-552
    • Jordan, J.H.1    Walchshofer, S.2    Jurecka, W.3
  • 50
    • 0037317839 scopus 로고    scopus 로고
    • Chymase expressing bone marrow mast cells in mastocytosis and myelodysplastic syndromes: an immunohistochemical and morphometric study
    • Horny HP, Greschniok A, Jordan JH et al. Chymase expressing bone marrow mast cells in mastocytosis and myelodysplastic syndromes: an immunohistochemical and morphometric study. J Clin Pathol 2003; 56(2): 103-106.
    • (2003) J Clin Pathol , vol.56 , Issue.2 , pp. 103-106
    • Horny, H.P.1    Greschniok, A.2    Jordan, J.H.3
  • 51
    • 84901294850 scopus 로고    scopus 로고
    • FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816H
    • Valent P, Blatt K, Eisenwort G et al. FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816H. Leuk Res Reports 2014; 3: 8-13.
    • (2014) Leuk Res Reports , vol.3 , pp. 8-13
    • Valent, P.1    Blatt, K.2    Eisenwort, G.3
  • 52
    • 84865645292 scopus 로고    scopus 로고
    • EuroFlow Consortium (EU-FP6, LSHBCT- 2006-018708). EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
    • van Dongen JJ, Lhermitte L, Böttcher S et al. EuroFlow Consortium (EU-FP6, LSHBCT- 2006-018708). EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia 2012; 26(9): 1908-1975.
    • (2012) Leukemia , vol.26 , Issue.9 , pp. 1908-1975
    • van Dongen, J.J.1    Lhermitte, L.2    Böttcher, S.3
  • 53
    • 0019461480 scopus 로고
    • Increased bone marrow mast cells in preleukemic syndromes, acute leukemia, and lymphoproliferative disorders
    • Prokocimer M, Polliack A. Increased bone marrow mast cells in preleukemic syndromes, acute leukemia, and lymphoproliferative disorders. Am J Clin Pathol 1981; 75(1): 34-38.
    • (1981) Am J Clin Pathol , vol.75 , Issue.1 , pp. 34-38
    • Prokocimer, M.1    Polliack, A.2
  • 54
    • 0034490248 scopus 로고    scopus 로고
    • Acute myeloblastic leukemia with differentiation to myeloblasts and mast cell blasts
    • Varma N, Varma S, Wilkins B. Acute myeloblastic leukemia with differentiation to myeloblasts and mast cell blasts. Br J Haematol 2000; 111(4): 991.
    • (2000) Br J Haematol , vol.111 , Issue.4 , pp. 991
    • Varma, N.1    Varma, S.2    Wilkins, B.3
  • 55
    • 84856184100 scopus 로고    scopus 로고
    • Mastocytosis and related disorders
    • Chiu A, Orazi A. Mastocytosis and related disorders. Semin Diagn Pathol 2012; 29 (1): 19-30.
    • (2012) Semin Diagn Pathol , vol.29 , Issue.1 , pp. 19-30
    • Chiu, A.1    Orazi, A.2
  • 56
    • 84878423607 scopus 로고    scopus 로고
    • International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis
    • Gotlib J, Pardanani A, Akin C et al. International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis. Blood 2013; 121(13): 2393-2401.
    • (2013) Blood , vol.121 , Issue.13 , pp. 2393-2401
    • Gotlib, J.1    Pardanani, A.2    Akin, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.